Mission
We empower the haematology community to share and harness data, advancing research and driving innovation to improve the lives of patients worldwide.
Vision
We imagine a future where open data sharing and scientific collaboration deliver personalised treatments and cures for patients with haematological malignancies.
Strategic Objectives
Innovation, data, and collaboration are our three main pillars to accelerate progress in the field of research in hematology.
Health Research, Innovation, and Scientific Advancement
- Promote scientific excellence through research, innovation, and Big Data analytics.
- Accelerate the translation of research into clinical practice to improve disease management and quality of life.
- Fund high-impact research projects in medicine and health sciences.
- Lead and support international collaborative research initiatives.
- Ensure that research outcomes contribute to better patient care and long-term impact on lives.
Data Management, Analytics, and Platform Development
- Expand and maintain the HARMONY Big Data Platform.
- Collect, curate, and analyse data to generate insights and advance discovery.
- Ensure data quality, privacy, and interoperability for real-world research.
Collaboration, Knowledge Exchange, and Outreach
- Strengthen collaboration through partnerships with public and private health research organisations.
- Organise and promote scientific events, training, and multi-stakeholder engagement.
- Share research findings with the broader scientific and clinical community.
Boards and Team
Governance
Board of Trustees
The Board of Trustees is the governing, representative, and management body of the Foundation which shall carry out the governance, representation, and administration of the Foundation in the best interests of the Foundation and for the better achievement of its purposes.
PROF. JESÚS MARÍA HERNÁNDEZ RIVAS
Chairman
PROF. KIMMO PORKKA
Secretary
PROF. HARTMUT DÖHNER
PROF. LARS BULLINGER
MR. JAN GEISSLER
DRA. MARÍA VICTORIA MATEOS MANTECA
MRS. ANANDA PLATE
Board of Advisors
PROF. PIETER SONNEVELD
Hematologist, EHA REPR.
RAÚL CÓRDOBA MASCUÑANO
Hematologist, EHA REPR.
CAROLINE HECKMAN
Researcher in Hematology
ANITA KIENESBERGER
Patient Representative
CARLOS ROYO SÁNCHEZ
IT Sector Repr. (GMV)
MARIA CRISTINA VISTOLI
Others’ Sectors Repr (INFN)
MARCO DIBONAVENTURA
Industry Repr. (PFIZER)
Data Hub
The HARMONY Alliance Foundation Data Hub provides scientific, technical, and analytical support across all disease areas to ensure the success of all the research projects carried out within the HARMONY Platform.
Data Analysts
ÁNGELA VILLAVERDE RAMIRO
Senior Data Analyst
HELENA FIDALGO GÓMEZ
Data Analyst
ÁNGELA VILLAVERDE RAMÍREZ
Data Analyst
HELENA FIDALGO GÓMEZ
Data Analyst
Data Harmonization team
ANA GARCÍA GAMBÍN
Biotechnologist
PABLO NEVADO LÓPEZ
Biotechnologist
ÁNGELA RODRÍGUEZ GARCÍA
Biotechnologist
MAYA SÁNCHEZ MARTÍNEZ
Biotechnologist
Data Quality Check and Curation Team
MARÍA ABÁIGAR ALVARADO
Researcher – Biologist
MIREYA MOROTE FAUBEL
Researcher – Biologist
MARÍA ABÁIGAR ALVARADO
PhD. Senior Data Scientist
MIREYA MOROTE FAUBEL
PhD. Senior Data Scientist
Executive Office
VALERIE BEHAN
Executive Director
SANTIAGO MORALEJO DEL ARCO
Senior Project Manager
ANA HERNÁNDEZ BLÁZQUEZ
Senior Project Manager
VALERIE BEHAN
Executive Director
SANTIAGO MORALEJO DEL ARCO
Senior Project Manager
ANA HERNÁNDEZ BLÁZQUEZ
Senior Project Manager
Would you like to collaborate with us?
Fostering data-driven collaborations since 2017
The HARMONY Alliance began as two ambitious projects funded under the Innovative Medicines Initiative (now IHI): HARMONY and HARMONY PLUS.
Launched in 2017 and 2020 respectively, these large-scale public–private partnerships brought together more than 100 organizations across Europe, including academic institutions, hospitals, patient organizations, regulatory agencies, and pharmaceutical companies.
The shared goal was to unlock the potential of Big Data to improve the treatment and care of patients with haematologic malignancies.
By building a secure, integrated platform containing anonymized data from over 120,000 patients, the HARMONY Alliance set a new benchmark for the use of real-world evidence in haematology.
Through data harmonization and collaborative research, it advanced disease classification, treatment evaluation, and patient stratification.
Following the successful completion of both projects, the infrastructure and momentum could not be left behind. To ensure sustainability and continued impact, this joint effort evolved into the HARMONY Alliance Foundation, a non-profit entity that now stewards the platform, promotes data sharing, and supports data-driven research. Today, the Foundation is a trusted partner for researchers, clinicians, and innovators seeking to advance precision medicine in blood cancers.
Snapshot of our achievements from IHI-funded phase
Community of 500+ experts
from all sorts of backgrounds: clinicians, researchers, patients, statisticians, data scientists, regulatory affairs specialists, ethics experts, and many more.
128 organizations involved
from +34 countries. Including: Hospitals, Academic institutions, Medical Associations, HTA Agencies, Regulators, Patient Organizations and Pharmaceutical Companies.
33 research projects
addressing key research questions and resulting in numerous scientific communications sent to international congresses.
Robust Big data Platform
with a GDPR-compliant data life-cycle, integrated data services, and visualization and prediction tools.
Data lake with +120,000 records
Containing data in AML, ALL, APL, CLL, CML, MDS, MM, MPN, NHL, and paediatric HMs.
100+ Databases
harmonized to OMOP common data model.